These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1148)

  • 1. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.
    Oostu K; Matsumoto T; Harada S; Kishi T
    Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Lankacidin group (T2636) antibiotics on the tumor growth and immune response against sheep erythrocytes in mice.
    Ootsu K; Matsumoto T
    Gan; 1973 Oct; 64(5):481-92. PubMed ID: 4801122
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumor and immunosuppressive effects of mycophenolic acid derivatives.
    Ohsugi Y; Suzuki S; Takagaki Y
    Cancer Res; 1976 Aug; 36(8):2923-7. PubMed ID: 1277202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). II. Experimental antitumor activity].
    Maral R; Bourat G; Fournel J; Ganter P; de Ratuld Y; Werner GH
    Arzneimittelforschung; 1967 Aug; 17(8):939-48. PubMed ID: 4299568
    [No Abstract]   [Full Text] [Related]  

  • 8. Oncostatic effects of Alangium vitiense extracts (ICIG-EORTC 1131, 1186 and 1207) on lymphoid murine tumors.
    Mathé G; Hayat M; Chenu E; Husson HP; Thevenet T; Kan C; Potier P
    Cancer Res; 1978 May; 38(5):1465-7. PubMed ID: 580415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contribution to the mechanism of drug inhibition of the graft vs host reaction.
    Levy L
    J Reticuloendothel Soc; 1973 Jan; 13(1):1-6. PubMed ID: 4144675
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor and immunosuppressive activities of alkyldithiopurine derivatives.
    Ootsu K; Matsumoto T; Aki O; Nakagawa Y; Sirakawa K
    Gan; 1972 Oct; 63(5):523-9. PubMed ID: 4645272
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
    Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
    Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E 1 on cellular and humoral immune responses.
    Loose LD; DiLuzio NR
    J Reticuloendothel Soc; 1973 Jan; 13(1):70-7. PubMed ID: 4144676
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of new semisynthetic saframycin derivatives.
    Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T
    Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of immunosuppressive effect of antitumor agents.
    Umezawa I; Komiyama K; Kasamatsu M; Hata T
    Kitasato Arch Exp Med; 1972 Dec; 45(3):181-91. PubMed ID: 4587766
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of rubomycin C on the formation of hemagglutinins in animals with transplanted tumors].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1969 Nov; 14(11):991-6. PubMed ID: 5395874
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
    LePage GA; Worth LS; Kimball AP
    Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
    Matsumoto T; Ootsu K; Okada Y
    Cancer Chemother Rep; 1974; 58(3):331-44. PubMed ID: 4152218
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunodepressive activity of cycloleucine (NSC-1026) in mice.
    Brambilla G; Cavanna M; Caraceni CE; Maura A
    Cancer Chemother Rep; 1972 Oct; 56(5):579-83. PubMed ID: 4569054
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and biological activity of spergualin analogues. I.
    Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
    J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.